Authors:
Ehret, A
Li-Weber, M
Frank, R
Krammer, PH
Citation: A. Ehret et al., The effect of HIV-1 regulatory proteins on cellular genes: derepression ofthe IL-2 promoter by Tat, EUR J IMMUN, 31(6), 2001, pp. 1790-1799
Authors:
Eichhorst, ST
Muller, M
Li-Weber, M
Schulze-Bergkamen, H
Angel, P
Krammer, PH
Citation: St. Eichhorst et al., A novel AP-1 element in the CD95 ligand promoter is required for inductionof apoptosis in hepatocellular carcinoma cells upon treatment with anticancer drugs, MOL CELL B, 20(20), 2000, pp. 7826-7837
Authors:
Hehner, SP
Li-Weber, M
Giaisi, M
Droge, W
Krammer, PH
Schmitz, ML
Citation: Sp. Hehner et al., Vav synergizes with protein kinase C Theta to mediate IL-4 gene expressionin response to CD28 costimulation in T cells, J IMMUNOL, 164(7), 2000, pp. 3829-3836
Citation: M. Li-weber et al., T cell activation-induced and HIV Tat-enhanced CD95(APO-1/Fas) ligand transcription involves NF-kappa B, EUR J IMMUN, 30(2), 2000, pp. 661-670
Authors:
Kirchhoff, S
Muller, WW
Li-Weber, M
Krammer, PH
Citation: S. Kirchhoff et al., Up-regulation of c-FLIPshort and reduction of activation-induced cell death in CD28-co-stimulated human T cells, EUR J IMMUN, 30(10), 2000, pp. 2765-2774
Citation: M. Li-weber et al., Novel Egr/NF-AT composite sites mediate activation of the CD95 (APO-1/Fas)ligand promoter in response to T cell stimulation, EUR J IMMUN, 29(9), 1999, pp. 3017-3027
Authors:
Miiller, M
Wilder, S
Bannasch, D
Israeli, D
Lehlbach, K
Li-Weber, M
Friedman, SL
Galle, PR
Stremmel, W
Oren, M
Krammer, PH
Citation: M. Miiller et al., p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs, J EXP MED, 188(11), 1998, pp. 2033-2045
Citation: M. Li-weber et al., Involvement of Jun and Rel proteins in up-regulation of interleukin-4 geneactivity by the T cell accessory molecule CD28, J BIOL CHEM, 273(49), 1998, pp. 32460-32466